Search filters

List of works by Bruce A Ruggeri

CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib

scientific article published on 5 December 2007

CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers

scientific article

Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes.

scientific article

PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas

scientific article

Paulina is supported by:

About Paulina

Help